602 related articles for article (PubMed ID: 9392331)
1. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
2. The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Erikson O; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säwe-Söderberg J
J Natl Cancer Inst Monogr; 1997; (22):53-5. PubMed ID: 9709276
[TBL] [Abstract][Full Text] [Related]
3. The Gothenburg Breast Screening Trial.
Bjurstam N; Björneld L; Warwick J; Sala E; Duffy SW; Nyström L; Walker N; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Salander H; Säve-Söderbergh J; Wahlin T
Cancer; 2003 May; 97(10):2387-96. PubMed ID: 12733136
[TBL] [Abstract][Full Text] [Related]
4. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
[TBL] [Abstract][Full Text] [Related]
5. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
[TBL] [Abstract][Full Text] [Related]
6. Updated results of the Gothenburg Trial of Mammographic Screening.
Bjurstam NG; Björneld LM; Duffy SW
Cancer; 2016 Jun; 122(12):1832-5. PubMed ID: 27061821
[TBL] [Abstract][Full Text] [Related]
7. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
Tabár L; Vitak B; Chen TH; Yen AM; Cohen A; Tot T; Chiu SY; Chen SL; Fann JC; Rosell J; Fohlin H; Smith RA; Duffy SW
Radiology; 2011 Sep; 260(3):658-63. PubMed ID: 21712474
[TBL] [Abstract][Full Text] [Related]
8. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
9. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
[TBL] [Abstract][Full Text] [Related]
10. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
Jonsson H; Nyström L; Törnberg S; Lenner P
J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
[TBL] [Abstract][Full Text] [Related]
11. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
Hellquist BN; Czene K; Hjälm A; Nyström L; Jonsson H
Cancer; 2015 Jan; 121(2):251-8. PubMed ID: 25242087
[TBL] [Abstract][Full Text] [Related]
13. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
14. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
15. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization.
Larsson LG; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabár L; Nyström L
J Natl Cancer Inst Monogr; 1997; (22):57-61. PubMed ID: 9709277
[TBL] [Abstract][Full Text] [Related]
16. Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening.
Ernst MF; Voogd AC; Coebergh JW; Roukema JA
Cancer; 2004 Apr; 100(7):1337-44. PubMed ID: 15042665
[TBL] [Abstract][Full Text] [Related]
17. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.
Tabar L; Fagerberg G; Chen HH; Duffy SW; Gad A
J Med Screen; 1995; 2(2):94-8. PubMed ID: 7497163
[TBL] [Abstract][Full Text] [Related]
18. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening.
Chiu SY; Duffy S; Yen AM; Tabár L; Smith RA; Chen HH
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1219-28. PubMed ID: 20406961
[TBL] [Abstract][Full Text] [Related]
19. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
Swedish Organised Service Screening Evaluation Group
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
[TBL] [Abstract][Full Text] [Related]
20. Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening.
Tabár L; Chen HH; Fagerberg G; Duffy SW; Smith TC
J Natl Cancer Inst Monogr; 1997; (22):43-7. PubMed ID: 9709274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]